Home » Business, Health & Medicine, News & Current Affairs, Pharmaceuticals & Biotech » Valneva SE, Transgene SA And NanoViricides, Inc. – Product Pipeline Review – 2015: Report By Radiant Insights, Inc.
“Radiant Insights”
New Market Research Reports Title “Valneva SE, Transgene SA And NanoViricides, Inc. – Product Pipeline Review – 2015” Has Been Added to RadiantInsights.com Report Database.

Valneva SE – Product Pipeline Review – 2015

‘Valneva SE – Product Pipeline Review – 2015’, provides an overview of the Valneva SE’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Valneva SE’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.


For More Information On “Valneva SE – Product Pipeline Review – 2015 ” visit:
http://www.radiantinsights.com/research/valneva-se-product-pipeline-review-2015


Transgene SA – Product Pipeline Review – 2015

‘Transgene SA – Product Pipeline Review – 2015’, provides an overview of the Transgene SA’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Transgene SA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

For More Information On “Transgene SA – Product Pipeline Review – 2015” visit:
http://www.radiantinsights.com/research/transgene-sa-product-pipeline-review-2015


NanoViricides, Inc. – Product Pipeline Review – 2015

‘NanoViricides, Inc. – Product Pipeline Review – 2015’, provides an overview of the NanoViricides, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of NanoViricides, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.


Browse All Reports of This Category at:
http://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare

The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.


For More Information On “NanoViricides, Inc. – Product Pipeline Review – 2015” visit:
http://www.radiantinsights.com/research/nanoviricides-inc-product-pipeline-review-2015


About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information, visit http://www.radiantinsights.com/

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: Califonia
Country: United States
Website: http://www.radiantinsights.com/research/valneva-se-product-pipeline-review-2015

Comments are closed.